NO965236L - Active substance carrier for controlled release of active substance in the gastrointestinal tract with exposed passage through the pylorus - Google Patents

Active substance carrier for controlled release of active substance in the gastrointestinal tract with exposed passage through the pylorus

Info

Publication number
NO965236L
NO965236L NO965236A NO965236A NO965236L NO 965236 L NO965236 L NO 965236L NO 965236 A NO965236 A NO 965236A NO 965236 A NO965236 A NO 965236A NO 965236 L NO965236 L NO 965236L
Authority
NO
Norway
Prior art keywords
active substance
pylorus
controlled release
gastrointestinal tract
carrier
Prior art date
Application number
NO965236A
Other languages
Norwegian (no)
Other versions
NO965236D0 (en
Inventor
Bodo Asmussen
Karsten Cremer
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO965236L publication Critical patent/NO965236L/en
Publication of NO965236D0 publication Critical patent/NO965236D0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

Et baneformig folielignende substrat forsynt med åpninger og tilsatt aktiv substans, blir anvendt som utgangsmateriale for fremstilling av en aktivsubstans-bærer for kontrollert frigjøring av aktiv substans i magetarmkanalen med utsatt passering gjennom pylorus.A web-like foil-like substrate provided with apertures and added active substance is used as the starting material for preparing an active substance carrier for controlled release of active substance into the gastrointestinal tract with exposed passage through the pylorus.

NO965236A 1994-06-07 1996-12-06 Active substance carrier for controlled release of active substance in the gastrointestinal tract with exposed passage through the pylorus NO965236D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4419818A DE4419818C2 (en) 1994-06-07 1994-06-07 Drug carrier for the controlled release of active substances in the gastrointestinal tract with delayed pyloric passage and method for producing the same
PCT/EP1995/002121 WO1995033449A1 (en) 1994-06-07 1995-06-03 Active substance carrier for the controlled release of active substances in the gastro-intestinal tract with delayed passage through the pylorus

Publications (2)

Publication Number Publication Date
NO965236L true NO965236L (en) 1996-12-06
NO965236D0 NO965236D0 (en) 1996-12-06

Family

ID=6519958

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965236A NO965236D0 (en) 1994-06-07 1996-12-06 Active substance carrier for controlled release of active substance in the gastrointestinal tract with exposed passage through the pylorus

Country Status (21)

Country Link
EP (1) EP0765158B1 (en)
JP (1) JP3801200B2 (en)
KR (1) KR100499898B1 (en)
CN (1) CN1204878C (en)
AT (1) ATE172875T1 (en)
AU (1) AU702676B2 (en)
CA (1) CA2192110C (en)
CZ (1) CZ356696A3 (en)
DE (2) DE4419818C2 (en)
DK (1) DK0765158T3 (en)
ES (1) ES2126287T3 (en)
FI (1) FI118952B (en)
HU (1) HU221675B1 (en)
IL (1) IL113930A (en)
MY (1) MY130546A (en)
NO (1) NO965236D0 (en)
NZ (1) NZ287884A (en)
PL (1) PL317378A1 (en)
SK (1) SK281043B6 (en)
WO (1) WO1995033449A1 (en)
ZA (1) ZA954650B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998009617A1 (en) * 1996-09-07 1998-03-12 Beisel Guenther Product with extender effect
DE19745208A1 (en) * 1997-10-13 1999-04-15 Labtec Gmbh Pharmaceutical film that dissolves in mouth
DE19757298A1 (en) 1997-12-22 1999-06-24 Basf Ag Process for the preparation of polymer powders
DE19822278A1 (en) * 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Device for the controlled release of active substance in the gastrointestinal tract with delayed pyloric passage
DE19849848A1 (en) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral application, spontaneous disintegration with liquid and dosage form and process for its preparation
FR2840221B1 (en) * 2002-06-04 2006-01-13 Backert Marie Elisabeth Cuine POLYMERIC FILM CONTAINING "ACTIVE" TO BE RELEASED IN A LIQUID
DE102007026037A1 (en) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentive system with alginate body
DE102011006844A1 (en) 2011-04-06 2012-10-11 Siemens Aktiengesellschaft Electric machine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624846A5 (en) * 1975-12-15 1981-08-31 Hoffmann La Roche Solid pharmaceutical unit dose form and process and apparatus for producing it
DE2746414A1 (en) * 1977-10-15 1979-04-26 Gerlach Eduard Chem Fab Foil-like tape for dispensing measured amts. of substance - consisting of the substance, binding agent and adjuvants, tape length being proportional to weight of substance
CA1273872A (en) * 1985-05-10 1990-09-11 Larry J. Caldwell Drug delivery device which can be retained in the stomach for a controlled period of time
EP0219762B1 (en) * 1985-10-09 1990-12-27 Desitin Arzneimittel GmbH Process for the preparation of an administration and dosage for drugs, reagents or other active substances
DE3630603A1 (en) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh PHARMACEUTICAL AND DOSAGE FORM FOR MEDICINAL ACTIVE SUBSTANCES, REAGENTS OR THE LIKE, AND METHOD FOR THE PRODUCTION THEREOF
JPH03163011A (en) * 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd Device stayed in stomach
GB9203474D0 (en) * 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel composition

Also Published As

Publication number Publication date
EP0765158A1 (en) 1997-04-02
EP0765158B1 (en) 1998-11-04
DK0765158T3 (en) 1999-07-19
PL317378A1 (en) 1997-04-01
JP3801200B2 (en) 2006-07-26
DE59504159D1 (en) 1998-12-10
ATE172875T1 (en) 1998-11-15
AU2674395A (en) 1996-01-04
DE4419818C2 (en) 1998-10-22
SK281043B6 (en) 2000-11-07
AU702676B2 (en) 1999-03-04
JPH10500974A (en) 1998-01-27
NZ287884A (en) 1997-10-24
DE4419818A1 (en) 1995-12-14
CZ356696A3 (en) 1997-03-12
HUT75862A (en) 1997-05-28
ZA954650B (en) 1996-01-26
SK157396A3 (en) 1997-09-10
FI964885L (en) 1996-12-05
FI964885A0 (en) 1996-12-05
CA2192110A1 (en) 1995-12-14
CA2192110C (en) 2006-05-02
IL113930A (en) 1999-10-28
HU221675B1 (en) 2002-12-28
KR100499898B1 (en) 2005-09-05
CN1204878C (en) 2005-06-08
CN1149826A (en) 1997-05-14
KR970703134A (en) 1997-07-03
NO965236D0 (en) 1996-12-06
HU9603326D0 (en) 1997-01-28
FI118952B (en) 2008-05-30
MY130546A (en) 2007-06-29
MX9606146A (en) 1998-06-30
WO1995033449A1 (en) 1995-12-14
IL113930A0 (en) 1995-08-31
ES2126287T3 (en) 1999-03-16

Similar Documents

Publication Publication Date Title
PT91560A (en) DEVICE FOR CONTROLLED RELEASE OF ACTIVE SUBSTANCES HAVING ASYMMETRIC MEMBRANES BASED ON CELLULOSE DERIVATIVES AND PROCESSES FOR PREPARING SAME
ATE303809T1 (en) ORAL FORM OF ADMINISTRATION CONTAINING A PROTON PUMP INHIBITOR (E.G. PANTOPRAZOLE)
BG42182A3 (en) Vaginal ring
ATE75936T1 (en) DELAYED-RELEASE COMPOSITIONS.
ATE164769T1 (en) PLASTERS WITH A HIGH CONTENT OF SOFTENING INGREDIENTS
NO912470D0 (en) PROCEDURE FOR THE PREPARATION OF A COMPOSITE LAYER ON A SUBSTRATE IN A DEVICE CONTAINING ELECTROLYTE IN STANDARD CONDITION.
DE3689150D1 (en) PRESSURE RELEASE, SOURCE AND DRYING DEVICE.
DK0951236T3 (en) Epikutant test patch
NO965236D0 (en) Active substance carrier for controlled release of active substance in the gastrointestinal tract with exposed passage through the pylorus
AU7078787A (en) Crystal on sub-strate
DE59706576D1 (en) ORAL PREPARATION CONTAINING IN A MATRIX SWELLABLE IN AQUEOUS MEDIUM AT LEAST ONE PHARMACEUTICAL ACTIVE SUBSTANCE
SE9900772D0 (en) Method and apparatus for enclosing application of a coating to a tablet, capsule, pill or the like
ES1004557U (en) The improved device freshener (Machine-translation by Google Translate, not legally binding)
JPS52146566A (en) Testing of semiconductor devices
JPS5237045A (en) Method for manufacturing electrophotographic light sensitive plate
JPS51119230A (en) Light sensitive material electronic photograph
JPS5344689A (en) Novel physiological active peptides and their derivatives
JPS5328164A (en) Maleimide derivatives
JPS5273957A (en) Temperature sensitive, light screening compositions and preparation th ereof
JPS52136994A (en) Adjuvant active sobstance
JPS5274627A (en) Adhering method
NO871336D0 (en) USE OF SUBSTANCE AS ELECTROMAGNETIC ACTIVE MATERIAL.
NO885069D0 (en) ORAL COMPOSITION CONTAINING PARTICLES INCLUDING AN ACTIVE SUBSTANCE.
JPS5430137A (en) 2,6-dichloro-(2'-carboxymethyl-cyclohexylidene)aniline

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application